HKD 0.06
(-3.23%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 470.33 Million HKD | 1.58% |
2022 | 509.35 Million CNY | -15.49% |
2021 | 602.68 Million CNY | -48.71% |
2020 | 1.17 Billion CNY | 41.54% |
2019 | 830.16 Million CNY | 31.52% |
2018 | 631.21 Million CNY | -20.66% |
2017 | 795.58 Million CNY | -20.41% |
2016 | 999.54 Million CNY | 9.39% |
2015 | 913.71 Million CNY | -38.37% |
2014 | 1.48 Billion CNY | -13.42% |
2013 | 1.71 Billion CNY | 8.92% |
2012 | 1.57 Billion CNY | 23.87% |
2011 | 1.26 Billion CNY | 51.45% |
2010 | 837.99 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 251.98 Million HKD | 0.0% |
2023 FY | 517.42 Million HKD | 1.58% |
2023 Q4 | 276.25 Million HKD | 0.0% |
2023 Q2 | 241.17 Million HKD | 0.0% |
2022 Q2 | 468.94 Million HKD | 0.0% |
2022 FY | 509.35 Million CNY | -15.49% |
2021 FY | 602.68 Million CNY | -48.71% |
2020 FY | 1.17 Billion CNY | 41.54% |
2019 FY | 830.16 Million CNY | 31.52% |
2018 FY | 631.21 Million CNY | -20.66% |
2017 FY | 795.58 Million CNY | -20.41% |
2016 FY | 999.54 Million CNY | 9.39% |
2015 FY | 913.71 Million CNY | -38.37% |
2014 FY | 1.48 Billion CNY | -13.42% |
2013 FY | 1.71 Billion CNY | 8.92% |
2013 Q4 | 370.61 Million CNY | -13.42% |
2013 Q3 | 428.05 Million CNY | 0.0% |
2013 Q2 | 428.05 Million CNY | 0.0% |
2013 Q1 | 428.05 Million CNY | 0.0% |
2012 Q4 | 428.05 Million CNY | 8.92% |
2012 Q1 | 393.01 Million CNY | 0.0% |
2012 FY | 1.57 Billion CNY | 23.87% |
2012 Q2 | 393.01 Million CNY | 0.0% |
2012 Q3 | 393.01 Million CNY | 0.0% |
2011 Q2 | 317.29 Million CNY | 0.0% |
2011 FY | 1.26 Billion CNY | 51.45% |
2011 Q4 | 393.01 Million CNY | 23.87% |
2011 Q3 | 317.29 Million CNY | 0.0% |
2011 Q1 | 317.29 Million CNY | 0.0% |
2010 FY | 837.99 Million CNY | 0.0% |
2010 Q4 | 317.29 Million CNY | 51.45% |
2010 Q3 | 209.49 Million CNY | 0.0% |
2010 Q2 | 209.49 Million CNY | 0.0% |
2010 Q1 | 209.49 Million CNY | 0.0% |
2009 Q4 | 209.49 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -39.974% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -7033.811% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -159.859% |
Huasheng International Holding Limited | 565.9 Million HKD | 16.889% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | -75.481% |
Evergreen Products Group Limited | 979.24 Million HKD | 51.97% |
EC Healthcare | 4.21 Billion HKD | 88.831% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 77.249% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 93.578% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -3018.707% |
Takbo Group Holdings Limited | 215.59 Million HKD | -118.159% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | 45.705% |